Surgical management of pancreatic cancer liver oligometastases

Rebekah Macfie; Yael Berger; Umut Sarpel; Spiros Hiotis; Benjamin Golas; Daniel Labow; Noah Cohen

doi:10.1016/j.critrevonc.2022.103654

Surgical management of pancreatic cancer liver oligometastases

Rebekah Macfie, Yael Berger, Umut Sarpel, Spiros Hiotis, Benjamin Golas, Daniel Labow, Noah Cohen

Research output: Contribution to journal › Review article › peer-review

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer, which commonly metastasizes to the liver. The current standard of care for metastatic PDAC is systemic chemotherapy, however there are limited emerging data regarding surgical resection of pancreatic oligometastases in select patients. Here we review the literature addressing resection of PDAC liver oligometastases.

Original language	English
Article number	103654
Journal	Critical Reviews in Oncology/Hematology
Volume	173
DOIs	https://doi.org/10.1016/j.critrevonc.2022.103654
State	Published - May 2022

Keywords

Carcinoma
Liver
Pancreatic Ductal
Standard of Care

Access to Document

10.1016/j.critrevonc.2022.103654

Cite this

@article{81e20fb99c46406d8a4e4c6fef8c576c,

title = "Surgical management of pancreatic cancer liver oligometastases",

abstract = "Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer, which commonly metastasizes to the liver. The current standard of care for metastatic PDAC is systemic chemotherapy, however there are limited emerging data regarding surgical resection of pancreatic oligometastases in select patients. Here we review the literature addressing resection of PDAC liver oligometastases.",

keywords = "Carcinoma, Liver, Pancreatic Ductal, Standard of Care",

author = "Rebekah Macfie and Yael Berger and Umut Sarpel and Spiros Hiotis and Benjamin Golas and Daniel Labow and Noah Cohen",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier B.V.",

year = "2022",

month = may,

doi = "10.1016/j.critrevonc.2022.103654",

language = "English",

volume = "173",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Surgical management of pancreatic cancer liver oligometastases

AU - Macfie, Rebekah

AU - Berger, Yael

AU - Sarpel, Umut

AU - Hiotis, Spiros

AU - Golas, Benjamin

AU - Labow, Daniel

AU - Cohen, Noah

PY - 2022/5

Y1 - 2022/5

N2 - Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer, which commonly metastasizes to the liver. The current standard of care for metastatic PDAC is systemic chemotherapy, however there are limited emerging data regarding surgical resection of pancreatic oligometastases in select patients. Here we review the literature addressing resection of PDAC liver oligometastases.

AB - Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer, which commonly metastasizes to the liver. The current standard of care for metastatic PDAC is systemic chemotherapy, however there are limited emerging data regarding surgical resection of pancreatic oligometastases in select patients. Here we review the literature addressing resection of PDAC liver oligometastases.

KW - Carcinoma

KW - Liver

KW - Pancreatic Ductal

KW - Standard of Care

UR - http://www.scopus.com/inward/record.url?scp=85127261000&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2022.103654

DO - 10.1016/j.critrevonc.2022.103654

M3 - Review article

C2 - 35301097

AN - SCOPUS:85127261000

SN - 1040-8428

VL - 173

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

M1 - 103654

ER -

Surgical management of pancreatic cancer liver oligometastases

Abstract

Keywords

Access to Document

Fingerprint

Cite this